https://www.selleckchem.com/pr....oducts/iodoacetamide
Secondary outcomes will include postoperative morbidity, mortality and postoperative AL-rates based on 90-day follow-up. A confirmatory analysis based on intention-to-treat will be performed. The ethics committee of the University of Zurich approved this study (2019-00562), which has been registered with on 14.11.2019 (NCT0416286 and the Swiss National Clinical Trials Portal (SNCTP000003524). The results of the study will be published and presented at appropriate conferences. The ethics committee of the University of Zurich appr
Like
Comment
Share
